[Leptin in patients wit nephrotic syndrome]

Area of Science:

• Endocrinology
• Nephrology
• Metabolic Syndrome

Background:

• Nephrotic syndrome (NS) involves proteinuria, hypoproteinemia, and hypercholesterolemia, often with edema.
• Metabolic alterations, including carbohydrate metabolism changes due to corticosteroids (CS), are common in NS.
• Leptin, a newly discovered hormone, may play a role in NS metabolic processes.

Purpose of the Study:

• To investigate plasma leptin and soluble leptin receptor (sLe-R) levels before and after CS treatment in NS patients.
• To evaluate the relationship between leptin/sLe-R and albuminemia/proteinuria.
• To understand leptin's role in the complex metabolic alterations of NS.

Main Methods:

• A study group of 30 newly diagnosed NS patients (15 male, 15 female) underwent renal biopsy and commenced CS treatment.
• Plasma leptin and sLe-R levels were measured at baseline, 1 month, and 6 months post-treatment.
• Body mass index (BMI), proteinuria, albumin, cholesterol, and other biochemical parameters were also assessed.

Main Results:

• A decrease in BMI and proteinuria, with significant improvements in serum cholesterol and albumin levels, was observed during treatment.
• No statistically significant changes were found in plasma leptin and sLe-R levels throughout the study.
• A trend towards a negative correlation between leptin and sLe-R was noted, though not statistically significant.

Conclusions:

• Plasma leptin and sLe-R levels appear to remain relatively stable in NS patients, irrespective of significant metabolic changes.
• The regulation of leptin in nephrotic syndrome is likely complex and multifactorial.
• Further research is needed to fully elucidate leptin's role and regulation in NS.